Abstract
Non-tuberculous mycobacteria (NTM) encompass a broad spectrum of organisms consisting of over 190 species. These organisms typically cause disease through environmental exposure, most commonly following trauma or procedures. The ocular manifestations of NTM are manifold, but due to the propensity of these organisms to form biofilms, the most notable manifestation has been multifocal chorioretinitis following cardiopulmonary bypass using heater-cooler units contaminated by M. chimaera. Treatment depends on the type of organism and its rate of growth. While some slow-growing NTM are susceptible to the four-drug therapeutic regimen used for tuberculosis (TB) treatment, the length of therapy is significantly longer than for TB. Some subtypes of NTM may be resistant to tuberculous therapy. The hardy nature of NTM may also create challenges in finding antibiotic regimens that can adequately penetrate the biofilms formed by these organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Daley CL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56
Koh W-J. Nontuberculous Mycobacteria—overview. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0024-2016.
Falkinham JO. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17:419–24. https://doi.org/10.3201/eid1703.101510.
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015;36:1–11. https://doi.org/10.1016/j.ccm.2014.10.001.
Falkinham JO. Challenges of NTM drug development. Front Microbiol. 2018;9:1613. https://doi.org/10.3389/fmicb.2018.01613.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. https://doi.org/10.1164/rccm.200604-571ST.
Shah M, Relhan N, Kuriyan AE, Davis JL, Albini TA, Pathengay A, et al. Endophthalmitis caused by nontuberculous mycobacterium: clinical features, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol. 2016;168:150–6. https://doi.org/10.1016/j.ajo.2016.03.035.
Huang SC, Soong HK, Chang JS, Liang YS. Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol. 1996;80:962–8. https://doi.org/10.1136/bjo.80.11.962.
Chandra NS, Torres MF, Winthrop KL, Bruckner DA, Heidemann DG, Calvet HM, et al. Cluster of Mycobacterium Chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol. 2001;132:819–30. https://doi.org/10.1016/S0002-9394(01)01267-3.
Moorthy RS, Valluri S, Rao NA. Nontuberculous mycobacterial ocular and adnexal infections. Surv Ophthalmol. 2012;57:202–35. https://doi.org/10.1016/j.survophthal.2011.10.006.
Girgis DO, Karp CL, Miller D. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management: ocular mycobacterial infections. Clin Exp Ophthalmol. 2012;40:467–75. https://doi.org/10.1111/j.1442-9071.2011.02679.x.
Holland SP, Pulido JS, Miller D, Ellis B, Alfonso E, Scott M, et al. Biofilm and scleral buckle-associated infections. Ophthalmology. 1991;98:933–8. https://doi.org/10.1016/S0161-6420(91)32199-7.
Chang V, Karp CL, Yoo SH, Ide T, Budenz DL, Kovach JL, et al. Mycobacterium abscessus endophthalmitis after Descemetʼs stripping with automated endothelial keratoplasty. Cornea. 2010;29:586–9. https://doi.org/10.1097/ICO.0b013e3181bd44b4.
Hsu C-R, Chen J-T, Yeh K-M, Hsu C-K, Tai M-C, Chen Y-J, et al. A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: clinical features and treatment outcomes. Eye. 2018;32:1504–11. https://doi.org/10.1038/s41433-018-0108-1.
Ambler JS, Meisler DM, Zakov ZN, Hall GS, Spech TJ. Endogenous mycobacterium chelonae endophthalmitis. Am J Ophthalmol. 1989;108:338–9. https://doi.org/10.1016/0002-9394(89)90136-0.
Williamson D, Howden B, Stinear T. Mycobacterium chimaera spread from heating and cooling units in heart surgery. N Engl J Med. 2017;376:600–2. https://doi.org/10.1056/NEJMc1612023.
Zweifel SA, Mihic-Probst D, Curcio CA, Barthelmes D, Thielken A, Keller PM, et al. Clinical and histopathologic ocular findings in disseminated Mycobacterium chimaera infection after cardiothoracic surgery. Ophthalmology. 2017;124:178–88. https://doi.org/10.1016/j.ophtha.2016.09.032.
Holt M, Kasperbauer S. Management of extrapulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2018;39:399–410. https://doi.org/10.1055/s-0038-1651490.
Chu H-S, Chang S-C, Shen EP, Hu F-R. Nontuberculous mycobacterial ocular infections—comparing the clinical and microbiological characteristics between mycobacterium abscessus and Mycobacterium massiliense. PLoS One. 2015;10:e0116236. https://doi.org/10.1371/journal.pone.0116236.
Mauriello JA, Atypical Mycobacterial Study Group. Atypical mycobacterial infection of the periocular region after periocular and facial surgery. Ophthal Plast Reconstr Surg. 2003;19:182–8. https://doi.org/10.1097/01.iop.0000064994.09803.cb.
Oz O, Lee DH, Smetana SM, Akduman L. A case of infected scleral buckle with mycobacterium chelonae associated with chronic intraocular inflammation. Ocul Immunol Inflamm. 2004;12:65–7. https://doi.org/10.1076/ocii.12.1.65.28069.
Pope J, Sternberg P, McLane NJ, Potts DW, Stulting RD. Mycobacterium chelonae scleral abscess after removal of a scleral buckle. Am J Ophthalmol. 1989;107:557–8. https://doi.org/10.1016/0002-9394(89)90511-4.
Margo CE. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol. 2000;118:1125. https://doi.org/10.1001/archopht.118.8.1125.
Smiddy WE, Miller D, Flynn HW. Scleral buckle infections due to atypical mycobacteria. Retina. 1991;11:394–8. https://doi.org/10.1097/00006982-199111040-00005.
Sossi N. Mycobacterium gordonae keratitis after penetrating keratoplasty. Arch Ophthalmol. 1991;109:1064. https://doi.org/10.1001/archopht.1991.01080080022011.
Lalitha P, Rathinam SR, Srinivasan M. Ocular infections due to non-tuberculous mycobacteria. Indian J Med Microbiol. 2004;22(4):231–7. https://pubmed-ncbi-nlm-nih-gov.ccmain.ohionet.org/17642744/.
Matieli LCV, De Freitas D, Sampaio J, Moraes NSB, Yu MCZ, Hofling-Lima AL. Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature. Retina. 2006;26:826–9. https://doi.org/10.1097/01.iae.0000244276.80716.96.
Ramaswamy A. Postoperative mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmology. 2000;107:1283–6. https://doi.org/10.1016/S0161-6420(00)00162-7.
Roussel TJ, Stern WH, Goodman DF, Whitcher JP. Postoperative mycobacterial endophthalmitis. Am J Ophthalmol. 1989;107:403–6. https://doi.org/10.1016/0002-9394(89)90664-8.
Cohen JI, Saragas SJ. Endophthalmitis due to Mycobacterium avium in a patient with AIDS. Ann Ophthalmol. 1990;22:47–51.
Rosenbaum PS. Atypical mycobacterial panophthalmitis seen with iris nodules. Arch Ophthalmol. 1998;116:1524. https://doi.org/10.1001/archopht.116.11.1524.
Morinelli EN, Dugel PU, Riffenburgh R, Rao NA. Infectious multifocal choroiditis in patients with acquired immune deficiency syndrome. Ophthalmology. 1993;100:1014–21. https://doi.org/10.1016/S0161-6420(93)31543-5.
Wassermann HE. Avian tuberculosis endophthalmitis. Arch Ophthalmol. 1973;89:321–3. https://doi.org/10.1001/archopht.1973.01000040323013.
Bhikoo R, Bevan R, Sims J. Multifocal choroiditis with panuveitis in a patient with disseminated mycobacterium avium complex. Retin Cases Brief Rep. 2013;7:155–7. https://doi.org/10.1097/ICB.0b013e3182790ef9.
Kuznetcova TI, Sauty A, Herbort CP. Uveitis with occult choroiditis due to mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol. 2012;32:499–506. https://doi.org/10.1007/s10792-012-9588-3.
Böni C, Al-Sheikh M, Hasse B, Eberhard R, Kohler P, Hasler P, et al. Multimodal imaging of choroidal lesions in disseminated mycobacterium chimaera infection after cardiothoracic surgery. Retina. 2019;39:452–64. https://doi.org/10.1097/IAE.0000000000001991.
Scriven JE, Scobie A, Verlander NQ, Houston A, Collyns T, Cajic V, et al. Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases. Clin Microbiol Infect. 2018;24:1164–70. https://doi.org/10.1016/j.cmi.2018.04.027.
Lau D, Cooper R, Chen J, Sim VL, McCombe JA, Tyrrell GJ, et al. Mycobacterium chimaera encephalitis following cardiac surgery: a new syndrome. Clin Infect Dis. 2019:ciz497. https://doi.org/10.1093/cid/ciz497.
Kasperbauer SH, Daley CL. Mycobacterium chimaera infections related to the Heater–Cooler unit outbreak: a guide to diagnosis and management. Clin Infect Dis. 2019;68:1244–50. https://doi.org/10.1093/cid/ciy789.
Daley CL. Mycobacterium avium complex disease. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0045-2017.
Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008–2015. Ann Am Thorac Soc. 2020;17:178–85. https://doi.org/10.1513/AnnalsATS.201804-236OC.
van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2015;36:43–54. https://doi.org/10.1016/j.ccm.2014.11.005.
Brown-Elliott BA, Philley JV. Rapidly growing mycobacteria. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0027-2016.
Duarte RS, Lourenco MCS, Fonseca LDS, Leao SC, Amorim EDLT, Rocha ILL, et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol. 2009;47:2149–55. https://doi.org/10.1128/JCM.00027-09.
Schnabel D, Gaines J, Nguyen DB, Esposito DH, Ridpath A, Yacisin K, et al. Rapidly growing nontuberculous mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic—Multiple States, March 2013–February 2014. MMWR Morb Mortal Wkly Rep. 2014;63:201–2.
Perkins KM, Lawsin A, Hasan NA, Strong M, Halpin AL, Rodger RR, et al. Notes from the field : Mycobacterium chimaera contamination of heater-cooler devices used in cardiac surgery — United States. MMWR Morb Mortal Wkly Rep. 2016;65:1117–8. https://doi.org/10.15585/mmwr.mm6540a6.
Asadi T, Mullin K, Roselli E, Johnston D, Tan CD, Rodriguez ER, et al. Disseminated Mycobacterium chimaera infection associated with heater–cooler units after aortic valve surgery without endocarditis. J Thorac Cardiovasc Surg. 2018;155:2369–74. https://doi.org/10.1016/j.jtcvs.2017.12.049.
Kasperbauer SH, De Groote MA. The treatment of rapidly growing mycobacterial infections. Clin Chest Med. 2015;36:67–78. https://doi.org/10.1016/j.ccm.2014.10.004.
van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34:103–9. https://doi.org/10.1055/s-0033-1333569.
Brown-Elliott BA, Nash KA, Wallace RJ. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25:545–82. https://doi.org/10.1128/CMR.05030-11.
Brown-Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol. 2019;57:e00834–19., /jcm/57/10/JCM.00834-19.atom. https://doi.org/10.1128/JCM.00834-19.
Wang M-S, Wang J-L, Wang X-F. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. BMC Pulm Med. 2016;16:163. https://doi.org/10.1186/s12890-016-0320-3.
Busin M, Ponzin D, Arffa RC. Mycobacterium chelonae interface infection after endokeratoplasty. Am J Ophthalmol. 2003;135:393–5. https://doi.org/10.1016/S0002-9394(02)01954-2.
Stewart MW, Alvarez S, Ginsburg WW, Shetty R, McLain WC, Sleater JP. Visual recovery following Mycobacterium chelonae endophthalmitis. Ocul Immunol Inflamm. 2006;14:181–3. https://doi.org/10.1080/09273940600678062.
Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Chemother. 2008;52:2019–26. https://doi.org/10.1128/AAC.00986-07.
Lee SH, Yoo HK, Kim SH, Koh W-J, Kim CK, Park YK, et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea. Ann Lab Med. 2014;34:31–7. https://doi.org/10.3343/alm.2014.34.1.31.
Griffith D. Treatment of Mycobacterium avium complex (MAC). Semin Respir Crit Care Med. 2018;39:351–61. https://doi.org/10.1055/s-0038-1660472.
Philley JV, Griffith DE. Treatment of slowly growing mycobacteria. Clin Chest Med. 2015;36:79–90. https://doi.org/10.1016/j.ccm.2014.10.005.
Peloquin C. The role of therapeutic drug monitoring in mycobacterial infections. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0029-2016.
Shulha JA, Escalante P, Wilson JW. Pharmacotherapy approaches in nontuberculous mycobacteria infections. Mayo Clin Proc. 2019;94:1567–81. https://doi.org/10.1016/j.mayocp.2018.12.011.
Egelund EF, Fennelly KP, Peloquin CA. Medications and monitoring in nontuberculous mycobacteria infections. Clin Chest Med. 2015;36:55–66. https://doi.org/10.1016/j.ccm.2014.11.001.
Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. Biomed Res Int. 2015;2015:1–17. https://doi.org/10.1155/2015/164989.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zheng, A., Miranda, C., Venkat, A. (2023). Nontuberculous Mycobacterial Infections. In: Lowder, C.Y., Shrestha, N., Venkat, A. (eds) Emerging Ocular Infections. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-24559-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-24559-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24558-9
Online ISBN: 978-3-031-24559-6
eBook Packages: MedicineMedicine (R0)